Total investments received (USD): 4.96m
Round value (USD): N/A
Company: MitoRx Therapeutics
Industry:
Biotech
Health services




Belgium
Netherlands
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain